SCHEMBL1995494

SCHEMBL1995494

CCN(CC)CCCS(=O)(=O)N[C@H](CCc1ccccc1)c1nc(Cc2ccc3c(c2)OCO3)n[nH]1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GHSR Q92847 1/20 0.57
ALDH1A1 P00352 4/20 0.39
HTR2A P28223 3/20 0.38
HTR2C P28335 3/20 0.38
HTR2B P41595 3/20 0.38
ADRB1 P08588 1/20 0.38
HTR1A P08908 1/20 0.38
ADRA2A P08913 1/20 0.38
DRD2 P14416 1/20 0.38
ADRA2B P18089 1/20 0.38
ADRA2C P18825 1/20 0.38
DRD1 P21728 1/20 0.38
DRD4 P21917 1/20 0.38
SLC6A2 P23975 1/20 0.38
ADRA1D P25100 1/20 0.38
HTR1D P28221 1/20 0.38
SLC6A4 P31645 1/20 0.38
HTR7 P34969 1/20 0.38
ADRA1A P35348 1/20 0.38
HRH1 P35367 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1991846 0.87 GHSR (0.71) GHSRALDH1A1HTR2AHTR2CHTR2B
SCHEMBL1996177 0.86 GHSR (0.46) GHSRALDH1A1HTR2AHTR2CHTR2B
SCHEMBL1988495 0.85 GHSR (0.62) GHSRHTR1AADRA2ADRD1SLC6A2
SCHEMBL1994284 0.85 GHSR (0.62) GHSRHTR1AADRA2ADRD1SLC6A2
SCHEMBL1990788 0.83 GHSR (0.78) GHSRALDH1A1HTR2AHTR2CADRB1
SCHEMBL10121964 0.83 GHSR (0.69) GHSRALDH1A1HTR1AADRA2ADRD1
SCHEMBL10121926 0.82 GHSR (0.67) GHSRALDH1A1HTR1AADRA2ADRD1
SCHEMBL1709708 0.82 GHSR (0.67) GHSRALDH1A1HTR1AADRA2ADRD1
SCHEMBL1996344 0.81 GHSR (0.40) GHSRALDH1A1HTR2AHTR2CHTR2B
SCHEMBL1709598 0.81 GHSR (0.58) GHSRALDH1A1LMNASMN1; SMN2POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110152232-A1 SULFONAMIDE COMPOUNDS AND USES THEREOF SAUNDERS JEFFREY O 2011-06-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110152232-A1 SULFONAMIDE COMPOUNDS AND USES THEREOF GHSR, GHRHR, SSTR2 GHSR 1/4885ALDH1A1 3514/4885HTR2A 605/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.